Literature DB >> 171053

Wilms' tumor--histologic variation and prognosis.

W Lawler, H B Marsden, M K Palmer.   

Abstract

A histologic analysis of 75 consecutive cases of Wilms' tumor in the Manchester (England) hospital region has been carried out. A classification based on the tubular status is described. A comparison of the histologic findings with the clinical staging and survival was undertaken, and it was found that the histologic classification was significantly correlated with both stage and survival.

Entities:  

Mesh:

Year:  1975        PMID: 171053     DOI: 10.1002/1097-0142(197509)36:3<1122::aid-cncr2820360343>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  An analysis of histology and DNA-ploidy in primary wilms tumors and their metastases and a study of the morphological effects of therapy.

Authors:  E H van Leeuwen; A Postma; J W Oosterhuis; A Meiring; C J Cornelisse; J Koudstaal; W M Molenaar
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Nephroblastoma and neuroblastoma--histology and prognosis.

Authors:  P Meister; M Middeke; H K Selbmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-10-30

3.  Wilms' tumour in adults. Review of 10 cases.

Authors:  P Winter; W Vahlensieck; W D Miersch; J Vogel; J M Gokel; U Hellerich
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 4.  Primary renal tumours in the first year of life. A population based review.

Authors:  H B Marsden; W Lawler
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

5.  Malignant rhabdoid tumor of the kidney. Histopathology, ultrastructure and comments on differential diagnosis.

Authors:  D Schmidt; D Harms; G Zieger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

6.  Prognostic relevance of DNA content in childhood renal tumours.

Authors:  S Kumar; H B Marsden; R A Cowan; J M Barnes
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.